Vol 13, No 6 (December 31, 2024): Chinese Clinical Oncology

Dural metastases in breast cancer: progression pattern, treatment and prognosis—a single center experience

Postoperative concurrent chemoradiotherapy plus apatinib for patients with high-grade glioma: a retrospective cohort study

The differences in the distribution characteristics and prognostic value of tumor-infiltrating T lymphocyte subsets between lung adenocarcinoma and lung squamous cell carcinoma

The feasibility of the deep hypothermal cryotherapy plus immune checkpoint inhibitor for treatment of severe malignant central airway obstruction

Tumour plasticity and tumour microenvironment interactions as potential immunologic targets for pancreatic cancer treatment

Advancing therapeutic frontiers in urothelial carcinoma: targeted strategies and clinical implications

E203K mutation in MAP2K1 (MEK1) causes acquired resistance to PD-1 blockade but responds to trametinib: a case report

Befotertinib in first-line treatment for Chinese non-small cell lung cancer patients harboring common EGFR-mutations reveals similar efficacy to other third-generation EGFR-TKIs but somewhat different safety profile

Artificial intelligence assistance during upper endoscopy: a game changer in detection of esophageal squamous cell carcinoma?

Benefit from addition of local therapy in oligometastatic oesophageal squamous cell carcinoma